In 2020, approximately 604 127 patients were newly diagnosed with cervical cancer and
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …

Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases
annually and approximately 350,000 cancer-related deaths per year. The disease burden is …

Background: Avoidable disparities in health outcomes persist in Canada despite substantial
investments in a publicly funded health care system that includes preventive services. Our …

Introduction In the past 2 decades, cervical cancer screening guidelines in the United States
have undergone numerous revisions with recent greater emphasis on primary high-risk …

Since government-provided annual cervical cytology testing for all Taiwanese women aged
30 years or older became available in 1995, both cervical cancer incidence and death have …

Objective To examine associations among women's preferred locations for human
papillomavirus (HPV) self-sampling in relation to their demographic, social, and health …

The majority of cervical cancer cases are due to human papillomavirus (HPV) infection.
However, certain cases of cervical cancer are not caused by HPV. Recent studies have …

Background: The effectiveness of cervical cancer screening programs is well recognized;
however, inappropriate screening practices result in either a woman being tested too often …

Résumé Contexte: Malgré des investissements importants dans un système de soins de
santé public qui comprend des services préventifs, on continue d'observer des disparités …

Human papillomavirus (HPV) is the necessary driver of cervical cancer, a disease that
largely affects females from underdeveloped nations and is prevalent among HIV-positive …